FYERS
Home
/
Stocks
/
Profit Loss
/
Nectar Lifesciences Profit & Loss

Nectar Lifesciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2006Sep 2005Jun 2005
₹44 L₹1 Cr₹0₹6 Cr₹60,000₹60,000₹60,000₹6 Cr₹359 Cr₹441 Cr₹452 Cr₹398 Cr₹394 Cr₹389 Cr₹344 Cr₹389 Cr₹403 Cr₹476 Cr₹443 Cr₹365 Cr₹385 Cr₹349 Cr₹378 Cr₹428 Cr₹390 Cr₹565 Cr₹648 Cr₹579 Cr₹575 Cr₹796 Cr₹733 Cr₹724 Cr₹593 Cr₹80 Cr₹80 Cr₹54 Cr
₹3 Cr₹6 Cr₹66 L₹3 L₹30 L₹18 L₹47 L₹69 L₹55 L₹1 Cr₹48 L₹11 Cr₹47 L₹18 Cr₹13 Cr₹11 Cr₹36 L₹52 L₹53 L₹5 Cr₹5 Cr₹1 Cr₹66 L₹53 L₹52 L₹11 L₹58 L₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹3 Cr₹2 L₹2 L
₹3 Cr₹8 Cr₹66 L₹6 Cr₹31 L₹18 L₹47 L₹6 Cr₹360 Cr₹443 Cr₹453 Cr₹409 Cr₹395 Cr₹407 Cr₹357 Cr₹399 Cr₹403 Cr₹477 Cr₹444 Cr₹370 Cr₹390 Cr₹350 Cr₹379 Cr₹428 Cr₹390 Cr₹565 Cr₹649 Cr₹580 Cr₹577 Cr₹797 Cr₹734 Cr₹725 Cr₹594 Cr₹83 Cr₹80 Cr₹54 Cr
₹28 Cr₹59 Cr₹2 Cr₹6 Cr₹17 L₹35 L₹12 L₹7 Cr₹335 Cr₹408 Cr₹425 Cr₹386 Cr₹374 Cr₹386 Cr₹357 Cr₹411 Cr₹376 Cr₹441 Cr₹411 Cr₹351 Cr₹364 Cr₹335 Cr₹360 Cr₹412 Cr₹388 Cr₹526 Cr₹607 Cr₹545 Cr₹530 Cr₹736 Cr₹684 Cr₹675 Cr₹549 Cr₹66 Cr₹66 Cr₹44 Cr
-₹24 Cr-₹51 Cr-₹1 Cr-₹30 L₹22 L₹14 L₹42 L₹10 L₹40 Cr₹50 Cr₹43 Cr₹37 Cr₹36 Cr₹36 Cr₹15 Cr₹3 Cr₹42 Cr₹50 Cr₹47 Cr₹33 Cr₹41 Cr₹30 Cr₹33 Cr₹32 Cr₹17 Cr₹54 Cr₹57 Cr₹49 Cr₹64 Cr₹76 Cr₹67 Cr₹66 Cr₹61 Cr₹21 Cr₹15 Cr₹12 Cr
₹16 L₹6 Cr₹30 Cr₹0₹0₹0₹0₹10,000₹20 Cr₹24 Cr₹25 Cr₹21 Cr₹18 Cr₹20 Cr₹17 Cr₹21 Cr₹21 Cr₹17 Cr₹18 Cr₹18 Cr₹26 Cr₹26 Cr₹31 Cr₹28 Cr₹28 Cr₹31 Cr₹31 Cr₹33 Cr₹31 Cr₹39 Cr₹36 Cr₹44 Cr₹30 Cr₹1 Cr₹3 Cr₹2 Cr
-₹25 Cr-₹57 Cr₹57 Cr-₹51 L₹14 L-₹16 L₹35 L-₹35 L₹5 Cr₹11 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr-₹18 Cr-₹32 Cr₹6 Cr₹18 Cr₹15 Cr₹39 L₹49 L-₹36 Cr-₹12 Cr-₹11 Cr-₹26 Cr₹8 Cr₹10 Cr₹3 Cr₹16 Cr₹23 Cr₹14 Cr₹7 Cr₹15 Cr₹16 Cr₹10 Cr₹8 Cr
-₹15 Cr-₹68 Cr₹14 Cr-₹176 Cr-₹63 Cr-₹130 Cr₹8 Cr₹6 Cr₹3 Cr₹59 L₹2 Cr₹1 Cr₹2 Cr₹4 Cr-₹9 Cr-₹22 Cr₹4 Cr₹12 Cr₹10 Cr₹2 Cr₹2 Cr-₹41 Cr-₹8 Cr-₹7 Cr-₹17 Cr₹7 Cr₹8 Cr₹2 Cr₹14 Cr₹18 Cr₹11 Cr₹6 Cr₹13 Cr₹15 Cr₹9 Cr₹7 Cr

Share Price Live Stats

Open (₹)10.10
Volume (₹)97,751.00
High (₹)10.30
Upper Circuit10.66
Low (₹)10.01
Lower Circuit9.66
Prev Close10.16
52W High (₹)22.40
Price10.01
52W Low (₹)9.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)196.01 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.00
Price to Book0.31
Book Value29.98
EPS (TTM)-12.61
Face Value1.00
ROE (%)-7.46

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
NECLIFENSE
LTP
1W Low
1W High
Market cap (₹)
1764+4 (0.23%)
1725.50
1778
4,19,620Cr
9030-310 (-3.32%)
8937.50
9431.50
2,39,714Cr
4584.1-72.8 (-1.56%)
4551.80
4682
1,74,741Cr
1140.2+22.7 (2.03%)
1107.30
1150.90
1,12,119Cr
2018.5-18.1 (-0.89%)
2007.80
2069.20
1,10,008Cr
1328+27 (2.08%)
1300.20
1336.40
1,06,061Cr
1218.8+21.8 (1.82%)
1196.90
1250.70
1,01,339Cr
2347.6-20.9 (-0.88%)
2317.50
2426.80
96,244Cr
1677.9-15.1 (-0.89%)
1647.10
1715
95,590Cr
1980.9+24.4 (1.25%)
1925.70
1990.90
89,391Cr
10.01-0.12 (-1.18%)
10
10.40
196Cr
Empty box

No content available